![Peter Fong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Fong
Président chez
ROCKET PHARMACEUTICALS, INC.
Fortune : 260 587 $ au 30/06/2026
Profil
Peter Marc Fong is the founder of Yarrow Biotechnology.
Dr. Fong is Chairman at Rocket Pharmaceuticals, Inc. since 2025.
Dr. Fong is Partner & President at RTW Investments LP since 2023, with the position starting in 2021.
Formerly, Dr. Fong was Chief Scientific Officer at Carigent Therapeutics, Inc. Dr. Fong was Senior Principal at Flagship Pioneering, LLC.
Dr. Fong was Principal at Yale University.
Dr. Fong completed undergraduate studies at Indiana University in 1995.
Dr. Fong earned graduate and doctorate degrees from Yale University in 2003.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/06/2026 | 76 195 ( 0,07 % ) | 260 587 $ | 30/06/2026 |
Postes actifs de Peter Fong
| Sociétés | Poste | Début |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Président | - |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments invests in companies located in the United States. The firm targets companies operating in the fields of med tech and biopharma sectors. It provides financing for early-stage capital requirements. | Private Equity Investor | 01/09/2021 |
Anciens postes connus de Peter Fong
| Sociétés | Poste | Fin |
|---|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Analyste en capital-investissement | - |
Carigent Therapeutics, Inc.
 Carigent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops Pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Formation de Peter Fong
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Carigent Therapeutics, Inc.
Carigent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops Pharmaceutical products | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments invests in companies located in the United States. The firm targets companies operating in the fields of med tech and biopharma sectors. It provides financing for early-stage capital requirements. | Finance |
Choisissez Zonebourse 
